Novel sequence variations in LAMA2 and SGCG genes modulating cis-acting regulatory elements and RNA secondary structure

Genetics and Molecular Biology

Volumn 33, Issue 1, 2010, Pages 190-197

  Siala, Olfa ^a   Salem, Ikhlass Hadj ^a   Tlili, Abdelaziz ^a   Ammar, Imen ^a   Belguith, Hanen ^a   Fakhfakh, Faiza ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Exon splicing enhancer; Muscular dystrophies; RNA fold; SR proteins

Indexed keywords

MESSENGER RNA; RNA;

ARTICLE; BASE PAIRING; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE EXPRESSION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PROTEIN SECONDARY STRUCTURE; RNA STRUCTURE;

EID: 77749246696     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572010005000008     Document Type: Article

References (37)

1. Addess KJ, Basilion JP, Klausner RD, Rouault TA and Pardi A (1997) Structure and dynamics of the iron responsive element RNA: Implications for binding of the RNA by iron regulatory binding proteins. J Mol Biol 274:72-83.
2. Allain FH, Gubser CC, Howe PW, Nagai K, Neuhaus D and Varani G (1996) Specificity of ribonucleoprotein interaction determined by RNA folding during complex formulation. Nature 380:646-650.
3. Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, Mieli-Vergani G and Thompson RJ (2009) Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 49:553-567.
4. Cartegni L, Wang J, Zhu Z, Zhang MQ and Krainer AR (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571.
5. Chasin LA (2007) Searching for splicing motifs. Adv Exp Med Biol 623:85-106.
6. Danièle N, Richard I and BartoliM(2007) Ins and outs of therapy in limb girdle muscular dystrophies. Int J Biochem Cell Biol 39:1608-1624.
7. Liegro CM, Bellafiore M, Izquierdo JM, Rantanen A and Cuezva JM (2000) 3′-untranslated regions of oxidative phosphorylation mRNAs function in vivo as enhancers of translation Biochem J 352:109-115.
8. Ding D and Lipshitz HD (1993) Localized RNAs and their functions. Bioessays 15:651-658.
9. Elkon R, Linhart C, Sharan R, Shamir R and Shiloh Y (2003) Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13:773-780.
10. Fairbrother WG, Holste D, Burge CB and Sharp PA (2004) Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biol 2:1388-1395.
11. Guglieri M, Magri F and Comi GP (2005) Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: Boundaries and contiguities. Clin Chim Acta 361:54-79.
12. Guicheney P, Vignier N, Zhang X, He Y, Cruaud C, Frey V, Helbling-Leclerc A, Richard P, Estournet B, Merlini L, et al. (1998) PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): Application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy. J Med Genet 35:211-217.
13. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tomé FM, Schwartz K, Fardeau M, Tryggvason K, et al. (1995) Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin- deficient congenital muscular dystrophy. Nat Genet 11:216-218.
14. Hofmann MH, Blievernicht JK, Klein K, Saussele T, Schaeffeler E, Schwab M and Zanger UM (2008) Aberrant splicing caused by single nucleotide polymorphism c.516G > T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver. J Pharmacol Exp Ther 325:284-292.
15. House AE and Lynch KW (2008) Regulation of alternative splicing: More than just the ABCs. J Biol Chem 283:1217-1221.
16. Kawasaki E (1990) Sample preparation from blood, cells and other fluids. In: M Innis, D Gelfand and J Snisky (eds) PCR Protocols: A Guide to Methods and Applications. Academic Press, San Diego, pp 146-152.
17. Lewandowska MA, Stuani C, Parvizpur A, Baralle FE and Pagani F (2005) Functional studies on the ATM intronic splicing processing element. Nucleic Acids Res 33:4007-4015.
18. Lund M and Kjems J (2002) Defining a 50 splice site by functional selection in the presence and absence of U1 snRNA 50 end. RNA 8:166-179.
19. Naom I, D'Alessandro M, Sewry CA, Jardine P, Philpot J, Manzur AY, Dubowitz V and Muntoni F (1998) Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy. Neuromusc Disord 8:495-501.
20. Nielsen KB, Sørensen S, Cartegni L, Corydon TJ, Doktor TK, Schroeder LD, Reinert LS, Elpeleg O, Krainer AR, Gregersen N, et al. (2007) Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: Asynonymous SNP in exon 5 ofMCADprotects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80:416-432.
21. Pelletier J and Sonenberg N (1987) The involvement of mRNA secondary structure in protein synthesis. Biochem Cell Biol 65:576-581.
22. Roeder K and Luca D (2009) Searching for disease susceptibility variants in structured populations. Genomics 93:1-4.
23. Roth FP, Hughes JD, Estep PW and Church GM (1998) Finding DNA regulatory motifs within unaligned noncoding sequences clustered by whole-genome mRNA quantitation. Nat Biotechnol 16:939-945.
24. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED and Moreau P (2003) The 14 bp deletion-insertion polymorphism in the 3- UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64:1005-1010.
25. Sachs AB (1993) MessengerRNAdegradation in eukaryotes. Cell 74:413-421.
26. Sheng LX and Tinoco JR (1995) The structure of an RNA pseudoknot that causes efficient frameshifting in mouse mammary tumor virus. J Mol Biol 247:963-978.
27. Siala O, Louhichi N, Triki CH, Morinière M, Fakhfakh F and Baklouti F (2008) LAMA2 mRNA processing alterations generate a complete deficiency of laminin alpha2 protein and a severe congenital muscular dystrophy. Neuromusc Disord 18:137-145.
28. St Johnston D (1995) The intracellular localization of messenger RNAs. Cell 81:161-170.
29. Tome FM, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, Barois A, Campbell KP and Fardeau M (1994) Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 317:351-357.
30. Wasserman WW, Palumbo M, Thompson W, Fickett JW and Lawrence CE (2000) Human-mouse genome comparisons to locate regulatory sites. Nat Genet 26:225-228.
31. Wang J, Smith PJ, Krainer, AR and Zhang MQ (2005) Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Res 33:5053-5062.
32. Zhang XH, Arias MA, Ke S and Chasin LA (2009) Splicing of designer exons reveals unexpected complexity in pre-mRNA splicing. RNA 15:367-376.
33. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, et al. (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104:20552-20557.
34. ZukerM(1994) Prediction of RNA secondary structure by energy minimization. Meth Mol Biol 25:267-294.
35. ESEfinder 3.0: http://rulai.cshl.edu/tools/ESE/ (July 28, 2009).
36. Enhancerfinder program: (http://violin. genet.sickkids.on.ca/~ali/ enhancerfinder.html (August 3, 2009).
37. MFOLD program: http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi (August 3, 2009).